Cargando…

Low molecular-weight heparin for thromboprophylaxis in patients undergoing gastric cancer surgery: an experience from one Korean institute

PURPOSE: This study evaluated the efficacy for preventing venous thromboembolism (VTE) and adverse effects of low-molecular-weight heparin (LMWH) in order to launch a prospective clinical trial in Korea. METHODS: We reviewed the medical records of 108 consecutive patients who underwent gastric cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Sung Ho, Shim, Jung Ho, Park, Cho Hyun, Song, Kyo Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994607/ https://www.ncbi.nlm.nih.gov/pubmed/24761403 http://dx.doi.org/10.4174/astr.2014.86.1.22

Ejemplares similares

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
por: Wei, Matthew Y., et al.
Publicado: (2015)

Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery – randomized, prospective pilot study
por: Biławicz, Jan, et al.
Publicado: (2020)

Is Routine Thromboprophylaxis Needed in Korean Patients Undergoing Unicompartmental Knee Arthroplasty?
por: Koh, In Jun, et al.
Publicado: (2016)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

Postpartum Heparin Thromboprophylaxis: More Harm Than Good
por: Kotaska, Andrew
Publicado: (2021)

Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials
por: Marcucci, Maura, et al.
Publicado: (2022)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis
por: Matsumoto, Mio, et al.
Publicado: (2015)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy
por: Lee, Jin Won, et al.
Publicado: (2015)

Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis
por: Kumar, Arun, et al.
Publicado: (2019)

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials
por: Yang, Hui-qin, et al.
Publicado: (2021)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents
por: Greiner, Jeanette, et al.
Publicado: (2019)

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
por: Pai, Menaka, et al.
Publicado: (2018)

Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
por: Ena, Javier, et al.
Publicado: (2022)

Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery
por: Aryal, Madan Raj, et al.
Publicado: (2015)

Thromboembolic Disease in Haemophilic Patients Undergoing Major Orthopaedic Surgery: Is Thromboprophylaxis Mandatory?
por: Badulescu, Oana Viola, et al.
Publicado: (2022)

Integral assays of hemostasis in hospitalized patients with COVID-19 on admission and during heparin thromboprophylaxis
por: Bulanov, Andrey Y., et al.
Publicado: (2023)

Thromboprophylaxis after bariatric surgery
por: Almarshad, Feras M., et al.
Publicado: (2020)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery
por: Gao, Yuan, et al.
Publicado: (2016)

Extended versus inpatient thromboprophylaxis with heparins following major open abdominopelvic surgery for malignancy: a systematic review of efficacy and safety
por: Heijkoop, B., et al.
Publicado: (2020)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial
por: Klaassen, Irene L. M., et al.
Publicado: (2017)

Thromboprophylaxis in spinal surgery: a survey
por: Bryson, David J, et al.
Publicado: (2012)

Aspirin thromboprophylaxis in joint replacement surgery
por: Sharda, Anish V., et al.
Publicado: (2022)

Thromboprophylaxis in Intramedullary Limb Lengthening Surgery
por: Iliadis, Alexios D, et al.
Publicado: (2020)

Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis
por: Caldeira, Daniel, et al.
Publicado: (2017)

Heparin Thromboprophylaxis in Simultaneous Pancreas-Kidney Transplantation: A Systematic Review and Meta-Analysis of Observational Studies
por: Ai Li, Erica, et al.
Publicado: (2023)

Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor
por: Cho, Jung Sun, et al.
Publicado: (2010)

Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis
por: Schiaffino, Simone, et al.
Publicado: (2021)

Changes in Treatment Outcomes of Gastric Cancer Surgery Over 45 Years at A Single Institution
por: Hyung, Woo Jin, et al.
Publicado: (2008)

The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
por: Kim, Kwang-Kyoun, et al.
Publicado: (2016)

Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
por: Giuliano, Karen K., et al.
Publicado: (2019)

Efficacy and Safety of Thromboprophylaxis Post-Orthopedic Surgery
por: Alsheikh, Khalid, et al.
Publicado: (2021)

A Prospective Observational Study to Determine Rate of Thromboprophylaxis in Oncology Patients Undergoing Abdominal or Pelvic Surgery
por: Shrikhande, Shailesh V., et al.
Publicado: (2021)

An unusual case of bilateral pulmonary embolism in a patient on dual venous thromboprophylaxis, secondary to heparin induced thrombocytopenia
por: Lixon, Antony, et al.
Publicado: (2018)

Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing
por: Engelen, Matthias M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a4ebsn3e6judrl7mrh7hpnt8n2